• Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity 

      Myhre, Peder Langeland; Heck, Siri Lagethon; Skranes, Julia Brox; Prebensen, Christian Haugland; Jonassen, Christine M; Berge, Trygve; Mecinaj, Albulena; Einvik, Gunnar; Melles, Woldegabriel A; Ingul, Charlotte Bjørk; Tveit, Arnljot; Berdal, Jan-Erik; Røsjø, Helge Rørvik; Lyngbakken, Magnus Nakrem; Omland, Torbjørn (Peer reviewed; Journal article, 2021)
      Background Coronavirus disease 2019 (COVID-19) may cause myocardial injury and myocarditis, and reports of persistent cardiac pathology after COVID-19 have raised concerns of long-term cardiac consequences. We aimed to ...
    • Exercise in individuals with atrial fibrillation 

      Myrstad, Marius; Malmo, Vegard; Ulimoen, Sara Reinvik; Tveit, Arnljot; Loennechen, Jan Pål (Journal article; Peer reviewed, 2018)
      Background Despite the high prevalence of atrial fibrillation (AF), there is a lack of recommendations for physical activity and exercise in individuals with AF, including athletes with AF. Methods With the aim to review ...
    • Prevalence and incidence rates of atrial fibrillation in Norway 2004-2014 

      Kjerpeseth, Lars Jøran; Igland, Jannicke; Selmer, Randi Marie; Ellekjær, Hanne; Tveit, Arnljot; Berge, Trygve; Kalstø, Silje Madeleine; Christophersen, Ingrid E.; Myrstad, Marius; Skovlund, Eva; Egeland, Grace M.; Tell, Grethe S.; Ariansen, Inger (Peer reviewed; Journal article, 2020)
      Objective To study time trends in incidence of atrial fibrillation (AF) in the entire Norwegian population from 2004 to 2014, by age and sex, and to estimate the prevalence of AF at the end of the study period. Methods A ...
    • Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study 

      Anjum, Mariam; Ariansen, Inger; Hjellvik, Vidar; Selmer, Randi Marie; Kjerpeseth, Lars Jøran; Skovlund, Eva; Myrstad, Marius; Ellekjær, Hanne; Christophersen, Ingrid E.; Tveit, Arnljot; Berge, Trygve (Peer reviewed; Journal article, 2023)
      Background and Aims The benefit of oral anticoagulant (OAC) therapy in atrial fibrillation (AF) and intermediate stroke risk is debated. In a nationwide Norwegian cohort with a non-sex CHA2DS2-VASc risk score of one, ...